SWK Holdings Corporation is a specialized investment firm focused on the life sciences sector, dedicated to delivering high-risk-adjusted returns through innovative financing solutions for transformative therapies. By issuing instruments such as its 9.00% Senior Notes due 2027, the firm actively funds promising opportunities within the healthcare market. Leveraging its deep industry expertise and a strategic investment approach, SWK is positioned to generate significant value for institutional investors while effectively managing the complexities of the evolving healthcare landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting